| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |